Trial Profile
Eptifibatide vs abciximab in STEMI patients undergoing PCI
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2013
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary) ; Abciximab
- Indications Cardiovascular disorders; Myocardial infarction
- Focus Therapeutic Use
- 06 Nov 2013 New trial record
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.